A novel antioxidant eyedrop shows promise with a first-in-class pharmaceutical approach to addressing one of the biggest remaining refractive challenges in ophthalmology.
See the impact of this rare autoimmune disease.
Read more about TEPEZZA.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2021 Horizon Therapeutics plc P-TEP-01183 08/21
Public & Patients
Museum of the Eye